Key advances In the SURMOUNT-1 trial for obesity, adults with overweight or obesity without type 2 diabetes mellitus achieved placebo-subtracted weight loss of up to 20% after 72 weeks of the GLP1GIP receptor co-agonist tirzepatide, with a similar safety profile to high-dose semaglutide 5
On the other hand, Akkermansia muciniphila can activate immune cells in the intestine, such as macrophages and dendritic cells, to secrete the anti-inflammatory cytokine IL-10 and inhibit the inflammatory response (Mei et al., 2024)
How to Deal with Lexapro Addiction and Misuse Dealing with anxiety, stress and depression can be very challenging, and there is nothing wrong with taking medication
A GLP-1-optimized diet supports treatment by reducing nausea and maintaining digestive health alongside medication
Type 2 Diabetes: Semaglutide for Cardiovascular Risk Reduction